Key highlights from Hikal Limited (HIKAL) Q3 FY22 Earnings Concall Management Update: HIKAL stated that the company expects some short term impact
Hikal Limited Q3 FY22 Earnings Conference Call Insights
Categories
pharmaceuticals
Orchid Pharma Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z2DK9xz1c8k Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY22 Earnings Concall Q&A Highlights: Viraj Kacharia from Securities Investment asked about the
JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=HiVTF6vv9q0 Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector with
NATCO Pharma Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=bt9cDow2-2c Key highlights from NATCO Pharma Limited (NATCOPHARM) Q3 FY22 Earnings Concall Q&A Highlights: Tarang Agrawal from Old Bridge asked about the
Glenmark Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform
Sequent Scientific Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=iqM668J91yY Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API order
Divi’s Laboratories Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=E7EoiAKzMn0 Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22 and
Divi’s Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Conference Call Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury -- Company Secretary and Compliance Officer
Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Transcript
Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha -- Chief Investor Relations
Piramal Enterprises Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Wh0LRTM3LTg Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Management Update: In financial service, PEL said it plans to
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY22 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
Jubilant Pharmova Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=wOzoHVd4itc Key highlights from Jubilant Pharmova Limited (JUBLPHARMA) Q3 FY22 Earnings Concall Management Update: JUBLPHARMA stated that its performance during 3Q was
Caplin Point Laboratories Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=3zJcH6WS7Fo Key highlights from Caplin Point Laboratories Ltd (CAPPL) Q3 FY22 Earnings Concall Management Update: In Caplin Steriles, CAPPL stated its last
Cadila Healthcare Ltd (CADILAHC) Q3 FY22 Earnings Concall Transcript
Cadila Healthcare Limited (NSE:CADILAHC) Q3 FY22 Earnings Concall dated Feb. 03, 2022 Corporate Participants: Ganesh Nayak -- Executive Sharvil P. Patel --
Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q3 FY22 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai -- Head of Investor Relations Dilip
Infographic: Key highlights from Sun Pharma Q3 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY22 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief Financial Officer
Cipla Limited (CIPLA) Q3 FY22 Earnings Concall Transcript
Cipla Limited (NSE:CIPLA) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Naveen Bansal -- Investor Relations Kedar Upadhye -- Global
Biocon Ltd (BIOCON) Q3 FY22 Earnings Concall Transcript
Biocon Limited (NSE:BIOCON) Q3 FY22 Earnings Concall dated Jan. 20, 2022 Corporate participants: Aishwarya Sitharam -- Head of Investor Relations Kiran Mazumdar
Infographic: All you need to know about Dr Reddy’s Labs Q2 performance
Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with a growth
Infographic: All you need to know about Divis Labs Q3 performance
Divi's Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release The company had net consolidated revenue of ₹2,006 crores with a growth of